Question 1

Does BlackRock own RNAC stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 819,239 shares of RNAC (Cartesian Therapeutics), worth $8.5M.

Question 2

How many shares of RNAC does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 819,239 shares of RNAC (Cartesian Therapeutics).

Question 3

What is BlackRock's RNAC position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's RNAC position is worth $8.5M.

Question 4

Is BlackRock buying or selling RNAC?

Accepted Answer

In Q2 2026, BlackRock increased its RNAC position by 220,131 shares (+36.7%).

Question 5

When did BlackRock first buy RNAC?

Accepted Answer

BlackRock already held RNAC in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	819,239	+36.7%	$8.5M	0.0%	$10.42	36
2026-Q1	Decreased	599,108	-1.7%	$3.7M	0.0%	$6.15	0
2025-Q4	Decreased	609,696	-6.1%	$4.4M	0.0%	$7.21	0
2025-Q3	Decreased	649,341	-0.7%	$6.6M	0.0%	$10.22	0
2025-Q2	Decreased	653,840	-2.9%	$6.8M	0.0%	$10.39	0
2025-Q1	Increased	673,050	+2.1%	$8.9M	0.0%	$13.18	28
2024-Q4	Increased	659,402	+55.7%	$11.8M	0.0%	$17.91	39
2024-Q3	First report	423,466	-	$6.8M	0.0%	$17.00	0